Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Brainsway Ltd. (OTC: BRSYF).

Full DD Report for BRSYF

You must become a subscriber to view this report.


Recent News from (OTC: BRSYF)

Brainsway reports FY results
Brainsway ( OTCPK:BRSYF ): FY Revenue of $11.1M (-3.5% Y/Y) Press Release More news on: Brainsway Ltd., Earnings news and commentary, Healthcare stocks news, ,
Source: SeekingAlpha
Date: March, 19 2018 16:35
Brainsway reports Q3 results
Brainsway ( OTC:BRSYF ): Q3 Non-GAAP income of $0.36M Revenue of $3.4M (+87% Y/Y) Press Release More news on: Brainsway Ltd., Earnings news and commentary, Healthcare stocks news, ,
Source: SeekingAlpha
Date: November, 28 2016 11:17
Brainsway reports Q1 results
Brainsway ( OTC:BRSYF ): Q1 net loss of $0.4M. More news on: Brainsway Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: June, 21 2016 09:06

 


About Brainsway Ltd. (OTC: BRSYF)

Logo for Brainsway Ltd. (OTC: BRSYF)

BrainsWay is dedicated to developing and providing advanced technology solutions for the treatment of a variety of brain disorders. The company was established in , and became a public company traded on the Tel Aviv Stock Exchange in January . BrainsWay s flagship technology is Deep TMS, or Deep Transcranial Magnetic Stimulation, which launches a new era in brain disorder treatment.

 

 

 

Current Share Structure

  • Market Cap: $53,230,365 - 05/11/2018
  • Issue and Outstanding: 11,828,970 - 12/15/2011

 



Daily Technical Chart for (OTC: BRSYF)

Daily Technical Chart for (OTC: BRSYF)


Stay tuned for daily updates and more on (OTC: BRSYF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BRSYF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

OTC Report
@OTCReporter

 

 


Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BRSYF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of BRSYF and does not buy, sell, or trade any shares of BRSYF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/